Recombinant interleukin-2 stimulates lymphocyte recovery in patients with severe COVID-19

A recently identified type of pneumonia, referred to as coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus-2, has rapidly spread worldwide. Lymphopenia and a proinflammatory cytokine storm frequently occur in patients with severe COVID-19. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Meng-En, Wang, Qian, Zhou, Shaoqiong, Wang, Bin, Ke, Li, He, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851620/
https://www.ncbi.nlm.nih.gov/pubmed/33603836
http://dx.doi.org/10.3892/etm.2021.9658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851620/
https://www.ncbi.nlm.nih.gov/pubmed/33603836
http://dx.doi.org/10.3892/etm.2021.9658

Ejemplares similares